Clinical Trials in Salt Lake City

Showing 10441-10460 of 16,694 trials

Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas

NCT03119467

A Phase I/Ib, Study to Evaluate Safety and Efficacy of RP4010, in Patients with Relapsed or Refractory Lymphomas

Rhizen Pharmaceuticals SA21 participantsStarted May 2017

Birmingham, Alabama, United States • Duarte, California, United States • Aurora, Colorado, United States +8 more locations

COMPLETEDPhase 3< 1 mile

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

NCT02943564

This study will evaluate the efficacy, safety, and tolerability of two doses of rapastinel, 225 milligrams (mg) and 450 mg, compared to placebo adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD) who have a partial response to ADT.

Depressive Disorder, Major

Naurex, Inc, an affiliate of Allergan plc658 participantsStarted Nov 2016

Birmingham, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +63 more locations

Safety and Efficacy Study of RP4010, in Patients With Relapsed or Refractory Lymphomas

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

Find Trials by Condition in Salt Lake City

12-Week Study of Plecanatide for CIC (The CIC3 Study)

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis

Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder

Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder

Pediatric Open-Label Extension Study

A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Monotherapy or in Combination With Bevacizumab (Avastin®) Compared to Sunitinib (Sutent®) in Participants With Untreated Advanced Renal Cell Carcinoma

Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris

Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis

Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing

Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder

EverFlex Post Approval Study

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors

Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment

A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients